The importance of a disintegrin and metalloproteinase (ADAM)10 and ADAM17 in the pathogenesis of psoriasis
- PMID: 35474465
- DOI: 10.1111/ced.15239
The importance of a disintegrin and metalloproteinase (ADAM)10 and ADAM17 in the pathogenesis of psoriasis
Erratum in
-
Corrigendum.Clin Exp Dermatol. 2022 Dec;47(12):2349. doi: 10.1111/ced.15390. Clin Exp Dermatol. 2022. PMID: 36440613 No abstract available.
Abstract
Background: Psoriasis is a chronic inflammatory skin disorder characterized by inflammation, hyperproliferation and neoangiogenesis. The disease pathogenesis has not been fully elucidated. The proteins, a disintegrin and metalloproteinase (ADAM)10 and ADAM17, are important proteases serving as regulators of inflammation.
Aim: To determine the role of ADAM10 and ADAM17 in the pathogenesis of psoriasis through the comparison of their serum levels in patients with psoriasis and healthy controls (HCs).
Methods: In total, 179 participants (90 patients with psoriasis and 89 HCs) were enrolled in the study. Levels of ADAM10 and ADAM17 in serum were measured by ELISA for each participant from the patient and HC groups. The statistical data analysis was performed using SPSS (V19.0) and P < 0.05 was considered statistically significant.
Results: The mean values for serum ADAM10 and ADAM17 were, respectively, 3.1 ± 2.2 and 76.5 ± 31.1 in the psoriasis group and 8.6 ± 3.7 and 29.5 ± 22.4 in the HC group. A statistically significant difference between the patient and HC groups was detected for both ADAM10 and ADAM17 levels (P = 0.001).
Conclusion: Considering the high levels of ADAM17 in the psoriasis group, ADAM17 protease might have a crucial role in the pathogenesis of psoriasis, while the low levels of ADAM10 might be attributable to its regulatory effect on keratinocyte differentiation and proliferation.
© 2022 British Association of Dermatologists.
Similar articles
-
The Autism Spectrum Disorder-Associated Bacterial Metabolite p-Cresol Derails the Neuroimmune Response of Microglial Cells Partially via Reduction of ADAM17 and ADAM10.Int J Mol Sci. 2022 Sep 20;23(19):11013. doi: 10.3390/ijms231911013. Int J Mol Sci. 2022. PMID: 36232346 Free PMC article.
-
The Antiatherogenic Effect of Fish Oil in Male Mice Is Associated with a Diminished Release of Endothelial ADAM17 and ADAM10 Substrates.J Nutr. 2015 Jun;145(6):1218-26. doi: 10.3945/jn.115.211375. Epub 2015 Apr 29. J Nutr. 2015. PMID: 25926412
-
Proteolytically active ADAM10 and ADAM17 carried on membrane microvesicles in human abdominal aortic aneurysms.Thromb Haemost. 2015 Nov 25;114(6):1165-74. doi: 10.1160/TH14-10-0899. Epub 2015 Sep 17. Thromb Haemost. 2015. PMID: 26422658
-
Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.Platelets. 2017 Jun;28(4):333-341. doi: 10.1080/09537104.2016.1184751. Epub 2016 Jun 2. Platelets. 2017. PMID: 27256961 Free PMC article. Review.
-
The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17.Int J Mol Sci. 2020 Dec 24;22(1):118. doi: 10.3390/ijms22010118. Int J Mol Sci. 2020. PMID: 33374371 Free PMC article. Review.
References
-
- Hugh JM, Weinberg JM. Update on the pathophysiology of psoriasis. Cutis 2018; 102: 6-12.
-
- Moss ML, Jin S-LC, Milla ME et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 1997; 385: 733-6.
-
- Black RA, Rauch CT, Kozlosky CJ et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 1997; 385: 729-33.
-
- Scheller J, Chalaris A, Garbers C et al. ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol 2011; 32: 380-7.
-
- Yong Bae W, Kook Park S, Hun Kim D et al. Expression of ADAM17 and ADAM10 in nasal polyps. Int Forum Allergy Rhinol 2016; 6: 731-6.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
